Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

被引:258
作者
Lehrke, Michael [1 ]
Becker, Alexander [2 ]
Greif, Martin [2 ]
Stark, Renee [3 ]
Laubender, Ruediger P. [4 ]
von Ziegler, Franz [2 ]
Lebherz, Corinna [2 ]
Tittus, Janine [2 ]
Reiser, Maximilian [5 ]
Becker, Christoph [5 ]
Goeke, Burkhard [1 ]
Leber, Alexander W. [2 ]
Parhofer, Klaus G. [1 ]
Broedl, Uli C. [1 ]
机构
[1] Univ Munich, Dept Internal Med 2, D-81377 Munich, Germany
[2] Univ Munich, Dept Internal Med 1, D-81377 Munich, Germany
[3] Helmholtz Zentrum, Munich, Germany
[4] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany
[5] Univ Munich, Dept Radiol, Munich, Germany
关键词
ADIPOKINE; ADIPOCYTE;
D O I
10.1530/EJE-09-0380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Chemerin is a recently discovered adipokine that regulates adipocyte differentiation and modulates chemotaxis and activation of dendritic cells and macrophages. Given the convergence of adipocyte and macrophage function, chemerin may provide an interesting link between obesity. inflammation and atherosclerosis in humans. We sought to examine the relationship of i) chemerin and markers of inflammation, ii) chemerin and components of the metabolic syndrome. and iii) chemerin and coronary atherosclerotic plaque burden and morphology. Design: Serum chemerin levels were determined in 303 patients with stable typical or atypical chest Pain Who Underwent dual-source multi-slice CT-angiography to exclude coronary artery stenosis. Atherosclerotic plaques were classified its calcified, mixed. or non-calcified. Results: Chemerin levels were highly correlated with high sensitivity C-reactive protein (r=0.44. P<0.0001). interleukin-6 (r=0.18, P=0.002), tumor necrosis factor-alpha. (r=0.24, P<0.0001). resistin (r=0.28. P<0.0001), and leptin r=0.36. P<0.0001) concentrations. Furthermore, chemerin was associated with components of the metabolic syndrome including body mass index (r=0.23, P=0.0002). triglycerides (r=0.29. P<0.0001), HDL-cholesterol (r=-0.18, P=0.003). and hypertension (P<0.0001). In bivariate analysis. chemerin levels were weakly correlated with coronary plaque burden (r=0.16. P=0.006) and the number of non-calcified plaques (r=0.14. P=0.02). These associations, however, were lost after adjusting for established cardiovascular risk factors (odds ratio. OR 1.17, 95%, confidence interval (Cl) 0.97-1.41. P=0.11 for coronary plaque burden: OR 1.06, 95% Cl 0.96-1.17. P=0.22 for non-calcified plaques). Conclusions: Chemerin is strongly associated with markers of inflammation and components of the metabolic syndrome. However, chemerin does not predict coronary, atherosclerosis.
引用
收藏
页码:339 / 344
页数:6
相关论文
共 18 条
  • [1] The genetic design of signaling cascades to record receptor activation
    Barnea, Gilad
    Strapps, Walter
    Herrada, Gilles
    Berman, Yemiliya
    Ong, Jane
    Kloss, Brian
    Axel, Richard
    Lee, Kevin J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (01) : 64 - 69
  • [2] Chemerin is a novel adipokine associated with obesity and metabolic syndrome
    Bozaoglu, Kiymet
    Bolton, Kristy
    McMillan, Janine
    Zimmet, Paul
    Jowett, Jeremy
    Collier, Greg
    Walder, Ken
    Segal, David
    [J]. ENDOCRINOLOGY, 2007, 148 (10) : 4687 - 4694
  • [3] Low Adiponectin Levels Are an Independent Predictor of Mixed and Non-Calcified Coronary Atherosclerotic Plaques
    Broedl, Uli C.
    Lebherz, Corinna
    Lehrke, Michael
    Stark, Renee
    Greif, Martin
    Becker, Alexander
    von Ziegler, Franz
    Tittus, Janine
    Reiser, Maximilian
    Becker, Christoph
    Goeke, Burkhard
    Parhofer, Klaus G.
    Leber, Alexander W.
    [J]. PLOS ONE, 2009, 4 (03):
  • [4] Synthetic chemerin-derived peptides suppress inflammation through ChemR23
    Cash, Jenna L.
    Hart, Rosie
    Russ, Andreas
    Dixon, John P. C.
    Colledge, William H.
    Doran, Joanne
    Hendrick, Alan G.
    Carlton, Mark B. L.
    Greaves, David R.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (04) : 767 - 775
  • [5] Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism
    Goralski, Kerry B.
    McCarthy, Tanya C.
    Hanniman, Elyisha A.
    Zabel, Brian A.
    Butcher, Eugene C.
    Parlee, Sebastian D.
    Muruganandan, Shanmugam
    Sinal, Christopher J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (38) : 28175 - 28188
  • [6] Pericardial Adipose Tissue Determined by Dual Source CT Is a Risk Factor for Coronary Atherosclerosis
    Greif, Martin
    Becker, Alexander
    von Ziegler, Franz
    Lebherz, Corinna
    Lehrke, Michael
    Broedl, Uli C.
    Tittus, Janine
    Parhofer, Klaus
    Becker, Christoph
    Reiser, Maximilian
    Knez, Andreas
    Leber, Alexander W.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (05) : 781 - U369
  • [7] The emerging role of adipokines as mediators of cardiovascular function:: Physiologic and clinical perspectives
    Gualillo, Oreste
    Ramon Gonzalez-Juanatey, Jose
    Lago, Francisca
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2007, 17 (08) : 275 - 283
  • [8] The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease
    Haffner, SM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (2A) : 3A - 11A
  • [9] Minireview: The adipocyte - At the crossroads of energy homeostasis, inflammation, and atherosclerosis
    Rajala, MW
    Scherer, PE
    [J]. ENDOCRINOLOGY, 2003, 144 (09) : 3765 - 3773
  • [10] Resistin is an inflammatory marker of atherosclerosis in humans
    Reilly, MP
    Lehrke, M
    Wolfe, ML
    Rohatgi, A
    Lazar, MA
    Rader, DJ
    [J]. CIRCULATION, 2005, 111 (07) : 932 - 939